Days after Eli Lilly and Company said it would stop a trial of its Covid-19 antibody therapy in hospitalized patients because it was not effective, the company on Wednesday published promising interim results from a trial involving patients with mild and moderate Covid-19.
Also on Wednesday, biopharmaceutical company Regeneron reported its monoclonal antibody cocktail treatment helped people with mild and moderate Covid-19.There are at least 78 monoclonal antibody treatments for Covid-19 in various stages of development in labs around the world, but those made by Lilly and Regeneron have been among the most closely watched.
The results didn't show any significant difference between the high and low dose of the treatment and because of that Regeneron is reviewing the dosage it will use in the ongoing outpatient trial, since there is a limited supply of the treatment.Regeneron said it has shared the results with the FDA as part of the paperwork submitted in its request for emergency use authorization. The company said it will also submit these results for publication.
We need more outpatient treatments
Kinda thinking donlemon might have covid. Caughing and sniffling?
Why isn’t Biden corruption trending number one on Twitter? Biggest world story, and nowhere to be found. There is no”trend”, only negative stories that Twitter wants to put up. Disgraceful! Section 230
Russians are having their problems too ,..
Trump is as fake as it gets. He is a fake all around